A Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Upadacitinib in Adult Subjects with Moderate to Severe Hidradenitis Suppurativa
Clinical Trial Grant
Administered By
Dermatology
Awarded By
AbbVie Inc.
Start Date
December 9, 2020
End Date
July 6, 2021
Administered By
Dermatology
Awarded By
AbbVie Inc.
Start Date
December 9, 2020
End Date
July 6, 2021